Cultivation Capital Life Sciences
SlowingSt. Louis, MOBiotechnology, Healthcare, Investment ManagementLast fund filed April 2025
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Cultivation Capital Life Sciences Fund IV | April 2025 | $40M | $6.5M | 0 |
| Cultivation Capital Life Sciences Fund II | October 2016 | $30M | $19M | 54 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
5 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| David SmollerNot on the current fund | Slowing | Biotech & pharma, AI & machine learning, Healthcare services | 8 | 1 |
| Bobby SandageNot on the current fund | Quiet | Biotech & pharma | 7 | 0 |
| Rick RyanNot on the current fund | Quiet | Biotech & pharma | 3 | 0 |
| Sean Morris | Quiet | Medical devices, Biotech & pharma, Fintech | 7 | 0 |
| William Schmidt | Quiet | Digital health, Medical devices | 7 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Cultivation Capital Life Sciences’s own portfolio companies, based on 29 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Cultivation Capital Life Sciences’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Rivervest | 2 | Adarza BioSystems, CARDIALEN |
| Arboretum Ventures | 1 | Fifth Eye |
A shared board seat: a company where filings name a Cultivation Capital Life Sciences partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.